410 related articles for article (PubMed ID: 19499868)
1. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
Ho KM; Robinson JO
Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
[TBL] [Abstract][Full Text] [Related]
2. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
[TBL] [Abstract][Full Text] [Related]
4. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
[TBL] [Abstract][Full Text] [Related]
5. Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia in Tampere University Hospital: a case-control study, Finland October 2002 to January 2010.
Rahikka P; Syrjänen J; Vuento R; Laine J; Huttunen R
Euro Surveill; 2011 Sep; 16(35):. PubMed ID: 21903040
[TBL] [Abstract][Full Text] [Related]
6. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge.
Wolkewitz M; Frank U; Philips G; Schumacher M; Davey P;
J Antimicrob Chemother; 2011 Feb; 66(2):381-6. PubMed ID: 21098543
[TBL] [Abstract][Full Text] [Related]
7. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
8. How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ?
Abernethy J; Sharland M; Johnson AP; Hope R
J Med Microbiol; 2017 Jun; 66(6):737-743. PubMed ID: 28598316
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
11. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Blot SI; Vandewoude KH; Hoste EA; Colardyn FA
Arch Intern Med; 2002 Oct; 162(19):2229-35. PubMed ID: 12390067
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
[TBL] [Abstract][Full Text] [Related]
13. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
14. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.
Hanberger H; Walther S; Leone M; Barie PS; Rello J; Lipman J; Marshall JC; Anzueto A; Sakr Y; Pickkers P; Felleiter P; Engoren M; Vincent JL;
Int J Antimicrob Agents; 2011 Oct; 38(4):331-5. PubMed ID: 21798720
[TBL] [Abstract][Full Text] [Related]
15. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
Rubio-Terrés C; Garau J; Grau S; Martinez-Martinez L;
Clin Microbiol Infect; 2010 Jun; 16(6):722-8. PubMed ID: 19712112
[TBL] [Abstract][Full Text] [Related]
16. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model.
Brown J; Paladino JA
Pharmacoeconomics; 2010; 28(7):567-75. PubMed ID: 20550222
[TBL] [Abstract][Full Text] [Related]
17. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.
Wyllie DH; Crook DW; Peto TE
BMJ; 2006 Aug; 333(7562):281. PubMed ID: 16798756
[TBL] [Abstract][Full Text] [Related]
18. Impact of the implementation of the Intelligent Antimicrobial System (iAMS) on clinical outcomes among patients with bacteraemia caused by methicillin-resistant Staphylococcus aureus.
Ho LC; Yu Chi C; You YS; Hsieh YW; Hou YC; Lin TC; Chen MT; Chou CH; Chen YC; Hsu KC; Yu J; Hsueh PR; Cho DY
Int J Antimicrob Agents; 2024 May; 63(5):107142. PubMed ID: 38490572
[TBL] [Abstract][Full Text] [Related]
19. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
20. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
